Food and Drug Administration
federal agency
Funding opportunities
PBPK Models to Aid the Development of Generic Dermatological Products
PBPK modeling and simulation tools have been extremely useful tool in the drug development process, in the interaction with regulatory agencies, and in decision...
PBPK Models of Oral Absorption to Simulate the Results of Bioequivalence Studies
PBPK models are an effective tool to integrate the product characteristics and the physiology of the individual subject along with its variability within a popu...
CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed
CBER seeks to advance the development of gene therapies for diseases affecting very small populations, potentially even single individuals, by enhancing innovat...
Drug Development Science Support (U01)
The Food and Drug Administration (FDA) Office of the Chief Scientist (OCS) and FDA Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP...
Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products
FDA's CTP is seeking to develop a smoking machine adaptor for use with electronic nicotine delivery system (ENDS), cigars, and heated tobacco products that will...
Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01)
The purpose of this funding opportunity is to incorporate social outcomes (quality of life, untreated pain, etc.) and cost effectiveness into FDA's existing mod...
Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
To support research projects that examine real-world data (RWD), real-world evidence (RWE), and related issues such as data analytics, the use of digital health...
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Ant...
An evidence-based clinical practice guideline for dental pain (surgical and non-surgical)
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (known as the SUPPORT Act) was signed into la...
Retail Food Safety Association Collaboration (U18) Clinical Trial Not Allowed
The intended outcome of this FOA is to collaboratively advance retail food initiatives to reduce foodborne illness. This cooperative agreement is intended to ad...
Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed
CBER, FDA seeks to support the development of innovative pathogen reduction technologies for whole blood and blood components to prevent transfusion-transmitted...
Development and Maintenance of the Animal Feed Regulatory Program Standards with Optional Coordinated Preventive Control Regulatory Activities and Capacity Building (U18) Clinical Trial Not Allowed
The intended outcome of this Funding Opportunity Announcement (FOA) is to advance efforts for a nationally integrated animal food safety system by assisting Sta...
FDA's National Curriculum Standard Development and Training Delivery and Development (ORA/OTED) (U18) Clinical Trial Not Allowed
The Food and Drug Administration's (FDA), Office of Regulatory Affairs (ORA), Office of Development (OTED) is announcing this Funding Opportunity Announcement (...